TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two…
CHICAGO, April 13, 2026 (GLOBE NEWSWIRE) -- Datatruck, the AI-native transportation management system (TMS) for carriers and freight brokers, today…
ROSLYN, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- EmPRO Insurance Company (EmPRO), a licensed medical professional liability insurance carrier serving…
Long-term offtake-backed green ammonia projects to strengthen domestic production and support India's clean energy transitionMUMBAI, India, April 13, 2026 /PRNewswire/…
GUANGZHOU, China, April 13, 2026 /PRNewswire/ -- The 28th edition of the China (Guangzhou) International Building Decoration Fair (CBD Guangzhou…
Join the Grand Opening Celebration on May 1, 2026, for an Evening of Beauty and Innovation April 10, 2026 19:12…
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated…
Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be earned if you purchase through links in this…
Los Angeles, CA, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not…
April 11, 2026 06:00 ET | Source: Garvee Innovation Inc. Ontario, California, April 11, 2026 (GLOBE NEWSWIRE) -- A high-level…